NCT07662603 Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing
| NCT ID | NCT07662603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Behcet Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-06 |
| Primary Completion | 2026-09-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-05-06 with a primary completion date of 2026-09-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated
Eligibility Criteria
Inclusion Criteria: * adlescent patients * complain Behcet disease * after pulmonary endoarterectomy Exclusion Criteria: * chronci cardiac diseases * psychic disease * mental disease
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07662603 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Behcet Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07662603 currently recruiting?
Yes, NCT07662603 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07662603 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07662603 clinical trial?
NCT07662603 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.